drugset / Trial / NCT07114848
Comparing Tamsulosin and Solifenacin for Relieving Double J Stent Symptoms: Using the USSQ.
RandomizedParallel-groupOpen-labelTreatment
Summary
This study evaluates the effects of two medications-tamsulosin and solifenacin-on symptoms associated with double J (DJ) ureteral stents. The research is conducted among patients undergoing unilateral DJ stent placement for ureteric calculi or post-ureteroscopic lithotripsy. Participants are randomly assigned to receive either tamsulosin or solifenacin, and symptom severity is assessed using the Ureteral Stent Symptom Questionnaire (USSQ).
Timeline
- Start
- 2024-06-13
- Primary completion
- 2024-12-30
- Completion
- 2025-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Solifenacin | Small molecule | 5 mg | — |
| Comparator | Tamsulosin | Other / unclassified | 0.4 mg | — |